Emma S. Jones
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Emergence of Ophidiomyces ophidiicola, Nannizziopsis barbatae and Paranannizziopsis in free-ranging Australian reptiles.
Journal: Australian veterinary journal
Published: November 26, 2025
Assessment and management of delirium in a tertiary hospital-Improvements in cognitive screening and use of non-pharmacological strategies with a multidisciplinary approach.
Journal: Australasian journal on ageing
Published: March 01, 2023
Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats.
Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats.
Journal: Clinical science (London, England : 1979)
Published: February 07, 2020
Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.
Journal: ACS pharmacology & translational science
Published: November 01, 2019
Necessary components of psychological treatment in pain management programs: A Delphi study.
Journal: European journal of pain (London, England)
Published: September 03, 2019
Simulated fate of catchment-derived sediment on the Great Barrier Reef shelf.
Journal: Marine pollution bulletin
Published: April 30, 2018
Threat and fear of pain induces attentional bias to pain words: An eye-tracking study.
Journal: European journal of pain (London, England)
Published: July 28, 2016
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
Journal: Clinical science (London, England : 1979)
Published: January 26, 2015
Novel adaptations in motor cortical maps: the relation to persistent elbow pain.
Journal: Medicine and science in sports and exercise
Published: August 08, 2014
Targeting chronic recurrent low back pain from the top-down and the bottom-up: a combined transcranial direct current stimulation and peripheral electrical stimulation intervention.
Journal: Brain stimulation
Published: December 21, 2013
Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
Journal: Kidney international
Published: May 14, 2013
Last Updated: 09/26/2026